Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes.
about
Diabetes melito: uma importante co-morbidade da fibrose císticaInsulin and oral agents for managing cystic fibrosis-related diabetesAppetite stimulants for people with cystic fibrosisInsulin and oral agents for managing cystic fibrosis-related diabetesInsulin and oral agents for managing cystic fibrosis-related diabetesUpdate on diagnosis and monitoring of cystic fibrosis-related diabetes mellitus (CFRD)Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine SocietyDiagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis.Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass.Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets.Comparison of cystic fibrosis-related diabetes with type 1 diabetes based on a German/Austrian Pediatric Diabetes Registry.Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.[Cystic fibrosis-related diabetes: a frequent co-morbidity].Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency?Evolving Mechanistic Views and Emerging Therapeutic Strategies for Cystic Fibrosis-Related Diabetes.Cystic Fibrosis-Related Diabetes.
P2860
Q22305909-618148E0-5F6E-4DC7-B6A4-4D9EEEF3EAD5Q24185897-790A982B-8A23-49F5-ACA6-A92CC6AED0E0Q24194798-8BE45E8B-764D-4A6F-B5D9-72172503C29EQ24201034-BB9C0F6F-6EAD-4538-8572-F785101F8E5BQ24246522-E8054E3C-5C79-49DC-9F3E-ECC4E1EED354Q26830633-D5A1BAA7-572C-4B87-8D47-BD3899C68520Q34351928-7B389814-3B49-4985-9EB8-E0872AB05A36Q35077819-A2D3F6CE-091C-4C82-B431-98FDC4BAE835Q35136628-394F866D-B81A-42F4-B6DB-AF7BA1596635Q36499679-4C2FF7BF-FE8D-493F-9947-5C947AF37FCBQ36720341-B8704D83-1FCD-4016-9B0B-76A34CF221CAQ37364992-BE933C64-3272-4AE2-AE5F-AB922A9AA4FCQ37470271-F9933CE1-2F5B-4EDD-9E34-134A35CDE460Q37882620-9AAC766D-1550-44D8-A7CF-712256D9D10EQ43957797-96049242-585A-4953-88B5-CDADC9DAA1A4Q51529221-0238AA7E-689C-41F2-84FC-212F4F9FA88EQ52739000-57C277A7-AFA8-40B9-AA24-EB399B57EAB4Q55376866-DB7753A9-37E9-4F8E-B5E5-04A4769E7155
P2860
Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Insulin and glucose excursion ...... tic fibrosis-related diabetes.
@en
Insulin and glucose excursion ...... tic fibrosis-related diabetes.
@nl
type
label
Insulin and glucose excursion ...... tic fibrosis-related diabetes.
@en
Insulin and glucose excursion ...... tic fibrosis-related diabetes.
@nl
prefLabel
Insulin and glucose excursion ...... tic fibrosis-related diabetes.
@en
Insulin and glucose excursion ...... tic fibrosis-related diabetes.
@nl
P2093
P1433
P1476
Insulin and glucose excursion ...... tic fibrosis-related diabetes.
@en
P2093
P304
P356
10.2337/DIACARE.24.10.1706
P407
P577
2001-10-01T00:00:00Z